Evaluation of patient outcomes after acute myocardial infarction in France
Official title: French Cohort of Myocardial Infarction Evaluation
Run by Assistance Publique - Hôpitaux de Paris · NCT04050956 · Data updated 2026-11-12
This study looks at how patients in France do after having a heart attack by collecting information on their care and recovery from hospitals and national health records.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30000 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | March 11, 2019 |
| Main results expected | March 22, 2029 |
| Study ends | March 22, 2049 |
| Registry record updated | June 25, 2025 |
| Trial ID | NCT04050956 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who have experienced an acute myocardial infarction within 48 hours of symptom onset.
✕Probably not a fit
Patients with iatrogenic myocardial infarction or those whose diagnosis is invalidated by another condition may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the profiles, management, and follow-up of patients who experience acute myocardial infarction (AMI) in France. It involves a multicenter registry that collects data from patients admitted to cardiac intensive care units within 48 hours of symptom onset. The study will link hospital data with national databases to evaluate clinical outcomes and healthcare consumption over time. By analyzing these factors, the study seeks to understand their relationship with patient outcomes post-AMI.
Why it matters
Potential benefit: If successful, this study could improve the understanding of AMI management and enhance patient care strategies.
How similar studies have gone: Other studies have shown success in evaluating patient outcomes in AMI, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements :
* Symptoms compatible with myocardial ischemia
* Appearance of pathological Q waves
* ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)
* Written consent.
* Covered by French medical insurance ("Sécurité Sociale")
Exclusion Criteria:
* Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure
* AMI diagnosis invalidated in favor of another diagnosis
Where it's running
-
Hôpital Bichat, AP-HP
Paris, France Recruiting
Study contacts
- Principal investigator: Philippe Gabriel STEG — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Tabassome SIMON
- Email: tabassome.simon@aphp.fr
- Phone: 01 40 01 13 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients
This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.
-
Adenosine given before primary PCI to reduce no-reflow in STEMI patients.
See if giving intracoronary adenosine before primary PCI lowers the chance of slow flow/no-reflow in adults with STEMI.
-
Subclinical depression in people after a first heart attack (SUBDIMA25)
This project will test how common mild depressive symptoms are in adults hospitalized for a first heart attack and whether those symptoms relate to biomarkers, heart function, and recovery over the next year.
-
Long-term follow-up after Hearticellgram-AMI treatment
We will follow people who got one dose of Hearticellgram-AMI after a heart attack for up to 60 months to see if the treatment stays safe.
-
Long-term remote ischemic preconditioning after a heart attack
This trial will test whether daily brief arm blood‑flow restriction after a recent heart attack can lower the chance of major heart and brain events over the following year for people treated for acute myocardial infarction.
-
Using wearable devices to monitor heart attack patients
This study tests whether wearable devices can help monitor heart attack patients in the hospital to improve their care and predict their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.